Examining the Impact of an Online, Non-restrictive Diet Among Persons With Multiple Sclerosis
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Stephanie L. Silveira
- Phone Number: 940-565-2373
- Email: stephanie.silveira@unt.edu
Study Locations
-
-
Texas
-
Denton, Texas, United States, 76203
- University of North Texas
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age 18-70 years
- a self-reported diagnosis of multiple sclerosis
- relapse free in past 30 days
- non-pregnant
- willing and able to visit University of North Texas on two testing occasions
Exclusion Criteria:
- electronic medical implant, such as a heart pacemaker or an implantable cardioverter defibrillator (ICD)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Diet Intervention
8 week non-restrictive diet program
|
The intervention will involve 8 weeks of an online diet program.
Outcomes testing will occur at baseline and post-intervention (following 8 week diet program).
During the first 4 weeks, participants will receive educaitonal material and log their daily points in an online application and attend a weekly check-in call with members of the research team.
During weeks 5-8, participants will log their daily points in the online application.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Metabolic Health
Time Frame: From recruitment to end of 8 week intervention
|
Fasted Cholesterol and Gloucose
|
From recruitment to end of 8 week intervention
|
|
Body Weight
Time Frame: From recruitment to end of 8 week intervention
|
Change in Body Weight
|
From recruitment to end of 8 week intervention
|
|
Body Fat
Time Frame: From recruitment to end of 8 week intervention
|
Change in Body Fat Percentage
|
From recruitment to end of 8 week intervention
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-Minute Walk
Time Frame: From recruitment to end of 8 week intervention
|
Change in 6-Minute Walk Distance
|
From recruitment to end of 8 week intervention
|
|
25-Foot Walk
Time Frame: From recruitment to end of 8 week intervention
|
Change in 25-Foot Walk Speed
|
From recruitment to end of 8 week intervention
|
|
Cognitive Assessments
Time Frame: From recruitment to end of 8 week intervention
|
Change in the Brief International Cognitive Assessment in MS Scores.
Scores range from 0-208 with higher scores indicating greater cognitive functioning.
|
From recruitment to end of 8 week intervention
|
|
Fatigue
Time Frame: From recruitment to end of 8 week intervention
|
Change in Fatigue Severity Scale Scores.
Scores range from 1-7 with higher scores indicating greater fatigue.
|
From recruitment to end of 8 week intervention
|
|
Health-Related Quality of Life
Time Frame: From recruitment to end of 8 week intervention
|
Change in SF-12 Scores.
Scores range from 0-100 with higher scores indicating greater health-related quality of life.
|
From recruitment to end of 8 week intervention
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of Intervention
Time Frame: From recruitment to end of 8 week intervention
|
Participants ratings of satisfaction with the diet program.
Scores range from 1-5 with higher scores indicating greater satisfaction.
|
From recruitment to end of 8 week intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Stephanie Silveira, University of North Texas Health Science Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRB-21-629
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.